AI & Machine Learning Startups
32,332 companies tagged AI & Machine Learning, with their investors and founders.
NeuroSky provides biofeedback and biometric assessment solutions that help companies optimize hiring decisions, identify employee training needs, and improve workforce productivity through data-driven insights on cognitive performance and employee capabilities.
1 investor
NeuroSmart develops technology that enables users to treat stress as a trainable skill through neuroscience-based approaches. The company is focused on digital health and behavioral wellness applications.
1 investor
Neurosom develops a wearable sleep therapy device called Sleep WISP that uses EEG monitoring and AI-driven electrical stimulation to improve deep sleep and reduce dementia risk. The system is designed for at-home use and targets patients seeking cognitive health and disease prevention.
1 investor
NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS. Its lead candidate, NTRX-07, is a CB2 receptor agonist designed to reduce neuroinflammation and promote neuronal survival.
1 investor
Neurotone develops auditory training software for hearing loss patients. The platform helps patients improve hearing comprehension through brain-based learning, built on over 20 years of clinical research in hearing care.
1 investor
NeuroTrainer offers a cognitive training system using virtual reality and neuroscience to improve mental performance skills for athletes and students. The platform is designed for coaches and educators to elevate cognitive abilities including focus, decision-making, reaction time, and situational awareness.
1 investor
NeuroTx develops AI-powered electroceutical and neurotechnology solutions that use neural decoding and non-invasive vagus nerve stimulation to support sleep quality, cognitive function, and metabolic health. The company integrates wearable devices, mobile applications, and machine learning to deliver personalized bio-signal-based interventions for consumers and patients.
1 investor
Neurotype provides AI software that helps clinicians convert multi-source case evidence (interviews, developmental histories, questionnaires, school input, GP letters, assessment notes) into structured, clinic-formatted draft diagnostic reports for ADHD and autism assessments, with the clinician retaining responsibility for judgment and sign-off. It targets neurodevelopmental diagnostic clinics across the UK and Ireland, aiming to cut report-writing time and increase assessment capacity.
1 investor
Neuroute is an AI-powered platform that accelerates clinical trial execution through patient recruitment, trial monitoring, and predictive analytics. It serves pharmaceutical companies and clinical research organizations conducting clinical trials.
1 investor
NeuroVirt provides mixed reality therapy software for stroke and neurorehabilitation, offering gamified exercises for upper and lower limb recovery in clinical and home settings with real-time motion tracking and clinician dashboards.
1 investor
NeuroXess is a life-science company founded in 2021 that develops implantable flexible brain-computer interface systems, with in-house development across hardware, algorithms, and software. Its technology aims to help patients with conditions such as ALS, high-level paraplegia, and stroke restore movement and speech functions.
1 investor
NeuroZen develops AI-based neuroimaging and genetic tools to predict, quantify, and monitor Alzheimer's disease and neurodegeneration, using multimodal clinical, neuropsychological, MRI, PET, and genomic data. Its products include AlzgenAI (genomic risk prediction), MemoAI (tablet-based cognitive testing), and NeuroAI (MRI/APOE-based amyloid PET positivity prediction), aimed at physicians for clinical decision-making, with a focus on Korean and Asian dementia cohorts.
1 investor
Neurvona offers Gmail Autopilot, a tool that researches a chosen number of contacts and drafts a tailored email for each, letting users review messages before sending from Gmail. It integrates with Google/Gmail and requests sending access only after a user approves their first email.
1 investor
Neutune builds infrastructure to establish content provenance for AI-generated and hybrid music, identifying which melodies, vocals, stems, and other components were used and who controls the rights to them. It aims to support rights identification, licensing, remuneration, and enforcement for artists, rights holders, and the music industry.
1 investor
Neuweb is an Australian AI video analytics company that delivers real-time monitoring and situational awareness solutions for retail, smart cities, traffic management, and critical infrastructure. The company's deep-learning platform helps organizations detect risks, prevent losses, and improve operational efficiency while maintaining data sovereignty and compliance with Australian privacy standards.
1 investor
Nevam provides a platform that visualizes the complete customer journey in real-time, combining journey mapping, data analytics, and AI agents to help marketing and business teams understand and optimize every customer touchpoint. The platform connects strategy to execution for enterprise organizations seeking cross-functional visibility and data-driven decision-making across the customer lifecycle.
1 investor
New Life Minds develops technology combining healthcare, life sciences, synthetic biology, and machine learning, with a stated focus on advancing brain evolution.
1 investor
New North Ventures is a venture capital firm run by former company operators and government professionals that invests in startups operating at the intersection of national security and economic resilience. It focuses on dual-use technology across national security, AI, and deep tech, helping founders navigate the space between startups and government.
1 investor
New Sapience builds "sapiens," a deterministic machine intelligence based on world-model directed-graph knowledge structures rather than machine learning or symbolic AI, used to automate decision-making and monitoring for critical infrastructure. It targets mission-critical operations across CISA-defined critical infrastructure sectors, offering expert human-in-the-loop judgement plus quantum-secure communications.
1 investor
New Street Tech provides MiFiX, a middleware platform that enables banks, NBFCs, and financial institutions to digitize loan origination, disbursement, and management across multiple products and use cases. The platform serves the financial services sector with specialized solutions for general banking, agricultural lending, cross-border remittances, and co-lending operations.
1 investor
An independent nonprofit academic research institution that convenes talent from academic, research, and medical institutions to advance collaborative genomic research and accelerate discoveries in the genetic basis of disease for clinical diagnosis and treatment.
1 investor
Newgen Software is a software product company that builds a low-code platform for digital process automation, content management, and enterprise workflow, serving industries such as banking, government, and healthcare across global markets. Founded in 1992, the company operates internationally including operations in the Americas, EMEA, and APAC.
1 investor
Wageningen Future Food Institute (WFFI) develops functional proteins such as lactoferrin and the sweet protein thaumatin through precision fermentation, operating its own technology platform and partner network for R&D through pilot-scale production. Based in Wageningen, it runs a research hub supporting precision-fermentation startups and works to build Sino-Dutch industry and academic partnerships.
1 investor
Newronika is a spin-off of Italian research institutions Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and the University of Milan that develops adaptive deep brain stimulation (αDBS) technology which responds to brain activity in real time. Its neuromodulation systems target Parkinson's disease and are being studied for a broader range of brain disorders, serving clinicians and patients.
1 investor








